A New Drug Design Targeting the Adenosinergic System for Huntington's Disease

BACKGROUND: Huntington's disease (HD) is a neurodegenerative disease caused by a CAG trinucleotide expansion in the Huntingtin (Htt) gene. The expanded CAG repeats are translated into polyglutamine (polyQ), causing aberrant functions as well as aggregate formation of mutant Htt. Effective treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Nai-Kuei, Lin, Jung-Hsin, Lin, Jiun-Tsai, Lin, Chia-I, Liu, Eric Minwei, Lin, Chun-Jung, Chen, Wan-Ping, Shen, Yuh-Chiang, Chen, Hui-Mei, Chen, Jhih-Bin, Lai, Hsing-Lin, Yang, Chieh-Wen, Chiang, Ming-Chang, Wu, Yu-Shuo, Chang, Chen, Chen, Jiang-Fan, Fang, Jim-Min, Lin, Yun-Lian, Chern, Yijuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3119665/
https://www.ncbi.nlm.nih.gov/pubmed/21713039
http://dx.doi.org/10.1371/journal.pone.0020934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3119665/
https://www.ncbi.nlm.nih.gov/pubmed/21713039
http://dx.doi.org/10.1371/journal.pone.0020934

Ejemplares similares